Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 8 , Pages 1332-1339 , August 2009

Comparison of 3 Needle Sizes for Trigger Point Injection in Myofascial Pain Syndrome of Upper- and Middle-Trapezius Muscle: A Randomized Controlled Trial

  • Seung-Hyun Yoon, MD, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon, Republic of Korea
    • Corresponding Author InformationReprint requests to Seung-Hyun Yoon, MD, PhD, Dept of Physical Medicine and Rehabilitation, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon 443-721, Republic of Korea
  • ,
  • Ueon Woo Rah, MD, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon, Republic of Korea
  • ,
  • Seung Soo Sheen, MD, MS

      Affiliations

    • Section of Clinical Epidemiology and Biostatistics in Clinical Trial Center, Ajou University Medical Center, Suwon, Republic of Korea
  • ,
  • Kye Hee Cho, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon, Republic of Korea

References 

  1. Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction: the trigger point manual (Vol 1, Upper half of body). 2nd ed.. Baltimore: Williams & Wilkins; 1999;
  2. Borg-Stein J, Simons DG. Myofascial pain. Arch Phys Med Rehabil. 2002;83:40–47
  3. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82:986–992
  4. Rubin D. Myofascial trigger point syndromes: an approach to management. Arch Phys Med Rehabil. 1981;62:107–110
  5. Jaeger B. Are “cervicogenic” headaches due to myofascial pain and cervical spine dysfunction?. Cephalalgia. 1989;9:157–164
  6. Rachlin ES. Myofascial pain and fibromyalgia. St Louis: Mosby; 2002;
  7. Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002;65:653–660
  8. Iwama H, Akama Y. The superiority of water-diluted 0.25% to neat 1% lidocaine for trigger-point injections in myofascial pain syndrome: a prospective, randomized, double-blinded trial. Anesth Analg. 2000;91:408–409
  9. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayık Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int. 2005;25:604–611
  10. Ready LB, Kozody R, Barsa JE, Murphy TM. Trigger point injections vs jet injection in the treatment of myofascial pain. Pain. 1983;15:201–206
  11. Botwin KP, Patel BC. Electromyographically guided trigger point injections in the cervicothoracic musculature of obese patients: a new and unreported technique. Pain Physician. 2007;10:753–756
  12. Ga H, Choi JH, Park CH, Yoon HJ. Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients—a randomised trial. Acupunct Med. 2007;25:130–136
  13. Lew HL, Lee EH, Castaneda A, Klima R, Date E. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil. 2008;89:75–80
  14. Altman DG, Bland JM. How to randomise. BMJ. 1999;11:703–704
  15. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994;56:217–226
  16. Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain. 2001;89:285–292
  17. Bech P. Health-related quality of life measurements in the assessment of pain clinic results. Acta Anaesthesiol Scand. 1999;43:893–896
  18. Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J. The chronic pain grade questionnaire: validation and reliability in postal research. Pain. 1997;71:141–147
  19. Schlenk EA, Erlen JA, Dunbar-Jacob J, McDowell J, Engberg S, Sereika SM. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res. 1997;7:57–65
  20. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II (Psychometric and clinical tests of validity in measuring physical and mental health constructs). Med Care. 1993;31:247–263
  21. Turner-Bowker DM, Bartley PJ, Ware JE. SF-36 Health Survey and “SF” bibliography (1988–2000). Lincoln: Quality Metric Inc; 2002;
  22. Ware JE. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute; 1994;
  23. Ware JE, Keller SD, Gandek B, Brazier JE, Sullivan M. Evaluating translations of health status questionnaires (Methods from the IQOLA project. International Quality of Life Assessment). Int J Technol Assess Health Care. 1995;11:525–551
  24. Itoh K, Katsumi Y, Hirota S, Kitakoji H. Randomised trial of trigger point acupuncture compared with other acupuncture for treatment of chronic neck pain. Complement Ther Med. 2007;15:172–179
  25. Tuzun EH, Albayrak G, Eker L, Sozay S, Daskapan A. A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil. 2004;26:198–202
  26. Dundar U, Evcik D, Samli F, Pusak H, Kavuncu V. The effect of gallium arsenide aluminum laser therapy in the management of cervical myofascial pain syndrome: a double blind, placebo-controlled study. Clin Rheumatol. 2007;26:930–934
  27. Pool JJ, Ostelo RW, Hoving JL, Bouter LM, de Vet HC. Minimal clinically important change of the neck disability index and the numerical rating scale for patients with neck pain. Spine. 2007;32:3047–3051
  28. Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27:485–489
  29. Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: is there a connection?. J Biopharm Stat. 2004;14:97–110
  30. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions (Results from the medical outcomes study). JAMA. 1989;262:907–913
  31. Bendtsen L, Jensen R, Olesen J. Qualitatively altered nociception in chronic myofascial pain. Pain. 1996;65:259–264
  32. Carlson CR, Okeson JP, Falace DA, Nitz AJ, Lindroth JE. Reduction of pain and EMG activity in the masseter region by trapezius trigger point injection. Pain. 1993;55:397–400
  33. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? (A review). Clin J Pain. 1997;13:116–137
  34. Roy R, Thomas M, Matas M. Chronic pain and depression: a review. Compr Psychiatry. 1984;25:96–105
  35. Magni G, Moreschi C, Rigatti-Luchini S, Merskey H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain. 1994;56:289–297
  36. Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003;4:331–339
  37. Walsh TL, Homa K, Hanscom B, Lurie J, Sepulveda MG, Abdu W. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey. Spine J. 2006;6:316–320
  38. Irnich D, Behrens N, Molzen H, et al. Randomised trial of acupuncture compared with conventional massage and “sham” laser acupuncture for treatment of chronic neck pain. BMJ. 2001;322:1574–1578
  39. Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23:37–43
  40. Egekvist H, Bjerring P, Arendt-Nielsen L. Pain and mechanical injury of human skin following needle insertions. Eur J Pain. 1999;3:41–49
  41. Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth. 1990;64:173–177
  42. Jorgensen JT. Improvement of patient convenience in treatment with growth hormone. J Pediatr Endocrinol. 1994;7:175–180
  43. Chantelau E, Lee DM, Hemmann DM, Zipfel U, Echterhoff S. What makes insulin injections painful?. BMJ. 1991;303:26–27
  44. Lee DM. How painful is intensive insulin therapy?. Z Gesamte Inn Med. 1992;47:266–269

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

PII: S0003-9993(09)00274-3

doi: 10.1016/j.apmr.2009.01.028

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 8 , Pages 1332-1339 , August 2009